# Knowles Corp: financial statements, quarterly

KN · NYSE · CIK 1587523 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/kn.md) · [Financials](/companies/kn/financials.md) · [Filings](/companies/kn/filings.md) · [Insiders](/companies/kn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/kn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [173](/filings/0001587523-24-000071.md) | [108](/filings/0001587523-24-000083.md) | [139 d](/filings/0001587523-26-000005.md) | [196](/filings/0001587523-24-000040.md) | [205](/filings/0001587523-24-000071.md) | [143](/filings/0001587523-24-000083.md) | [143 d](/filings/0001587523-26-000005.md) | [132](/filings/0001587523-26-000018.md) | [146](/filings/0001587523-25-000066.md) | [153](/filings/0001587523-25-000079.md) | [162 d](/filings/0001587523-26-000005.md) | [153](/filings/0001587523-26-000018.md) |
| Cost of revenue | $m | [106](/filings/0001587523-24-000071.md) | [57.5](/filings/0001587523-24-000083.md) | [79.7 d](/filings/0001587523-26-000005.md) | [79.1](/filings/0001587523-25-000037.md) | [77.1](/filings/0001587523-25-000066.md) | [79.5](/filings/0001587523-25-000079.md) | [81.1 d](/filings/0001587523-26-000005.md) | [78.4](/filings/0001587523-26-000018.md) | [81.7](/filings/0001587523-25-000066.md) | [82.8](/filings/0001587523-25-000079.md) | [89.6 d](/filings/0001587523-26-000005.md) | [85.9](/filings/0001587523-26-000018.md) |
| Gross profit | $m | [73.7](/filings/0001587523-24-000071.md) | [50.4](/filings/0001587523-24-000083.md) | [58.6 d](/filings/0001587523-26-000005.md) | [53.2](/filings/0001587523-25-000037.md) | [57.8](/filings/0001587523-25-000066.md) | [62.9](/filings/0001587523-25-000079.md) | [60.9 d](/filings/0001587523-26-000005.md) | [53.3](/filings/0001587523-26-000018.md) | [60.6](/filings/0001587523-25-000066.md) | [69.9](/filings/0001587523-25-000079.md) | [72.5 d](/filings/0001587523-26-000005.md) | [67.1](/filings/0001587523-26-000018.md) |
| Research and development | $m | [19.7](/filings/0001587523-24-000071.md) | [8.1](/filings/0001587523-24-000083.md) | [8.4 d](/filings/0001587523-26-000005.md) | [9.4](/filings/0001587523-25-000037.md) | [9.6](/filings/0001587523-25-000066.md) | [10.2](/filings/0001587523-25-000079.md) | [10.3 d](/filings/0001587523-26-000005.md) | [9.7](/filings/0001587523-26-000018.md) | [10.0](/filings/0001587523-25-000066.md) | [10.0](/filings/0001587523-25-000079.md) | [10.5 d](/filings/0001587523-26-000005.md) | [11.7](/filings/0001587523-26-000018.md) |
| Selling, general and administrative | $m | [36.5](/filings/0001587523-24-000071.md) | [29.4](/filings/0001587523-24-000083.md) | [38.5 d](/filings/0001587523-26-000005.md) | [37.3](/filings/0001587523-25-000037.md) | [35.6](/filings/0001587523-25-000066.md) | [33.9](/filings/0001587523-25-000079.md) | [35.2 d](/filings/0001587523-26-000005.md) | [37.2](/filings/0001587523-26-000018.md) | [35.9](/filings/0001587523-25-000066.md) | [34.0](/filings/0001587523-25-000079.md) | [35.7 d](/filings/0001587523-26-000005.md) | [39.4](/filings/0001587523-26-000018.md) |
| Operating income | $m | [16.9](/filings/0001587523-24-000071.md) | [11.4](/filings/0001587523-24-000083.md) | [11.3 d](/filings/0001587523-26-000005.md) | [5.0](/filings/0001587523-25-000037.md) | [12.7](/filings/0001587523-25-000066.md) | [18.7](/filings/0001587523-25-000079.md) | [15.4 d](/filings/0001587523-26-000005.md) | [4.0](/filings/0001587523-26-000018.md) | [14.7](/filings/0001587523-25-000066.md) | [25.8](/filings/0001587523-25-000079.md) | [25.8 d](/filings/0001587523-26-000005.md) | [15.9](/filings/0001587523-26-000018.md) |
| Income tax | $m | [3.8](/filings/0001587523-24-000071.md) | [(3.9)](/filings/0001587523-24-000083.md) | [(18.7) d](/filings/0001587523-26-000005.md) | [2.0](/filings/0001587523-25-000037.md) | [3.0](/filings/0001587523-25-000066.md) | [3.0](/filings/0001587523-25-000079.md) | [3.3 d](/filings/0001587523-26-000005.md) | [1.2](/filings/0001587523-26-000018.md) | [3.5](/filings/0001587523-25-000066.md) | [4.3](/filings/0001587523-25-000079.md) | [4.1 d](/filings/0001587523-26-000005.md) | [(0.3)](/filings/0001587523-26-000018.md) |
| Net income | $m | [13.6](/filings/0001587523-24-000071.md) | [16.6](/filings/0001587523-24-000083.md) | [47.4 d](/filings/0001587523-26-000005.md) | [2.5](/filings/0001587523-25-000037.md) | [(259)](/filings/0001587523-25-000066.md) | [0.5](/filings/0001587523-25-000079.md) | [18.5 d](/filings/0001587523-26-000005.md) | [(2.0)](/filings/0001587523-26-000018.md) | [7.8](/filings/0001587523-25-000066.md) | [17.4](/filings/0001587523-25-000079.md) | [21.0 d](/filings/0001587523-26-000005.md) | [9.7](/filings/0001587523-26-000018.md) |
| Diluted EPS | $ per share | [0.15](/filings/0001587523-24-000071.md) | [0.18](/filings/0001587523-24-000083.md) | not reported | [0.03](/filings/0001587523-25-000037.md) | [(2.88)](/filings/0001587523-25-000066.md) | [0.01](/filings/0001587523-25-000079.md) | not reported | [(0.02)](/filings/0001587523-26-000018.md) | [0.09](/filings/0001587523-25-000066.md) | [0.20](/filings/0001587523-25-000079.md) | not reported | [0.11](/filings/0001587523-26-000018.md) |
| Basic EPS | $ per share | [0.15](/filings/0001587523-24-000071.md) | [0.18](/filings/0001587523-24-000083.md) | not reported | [0.03](/filings/0001587523-25-000037.md) | [(2.90)](/filings/0001587523-25-000066.md) | [0.01](/filings/0001587523-25-000079.md) | not reported | [(0.02)](/filings/0001587523-26-000018.md) | [0.09](/filings/0001587523-25-000066.md) | [0.20](/filings/0001587523-25-000079.md) | not reported | [0.11](/filings/0001587523-26-000018.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue, us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [54.4](/filings/0001587523-23-000071.md) | [75.1](/filings/0001587523-23-000081.md) | [87.3](/filings/0001587523-25-000010.md) | [122](/filings/0001587523-24-000040.md) | [84.0](/filings/0001587523-24-000071.md) | [92.6](/filings/0001587523-24-000083.md) | [130](/filings/0001587523-26-000005.md) | [102](/filings/0001587523-25-000037.md) | [103](/filings/0001587523-25-000066.md) | [92.5](/filings/0001587523-25-000079.md) | [54.2](/filings/0001587523-26-000018.md) | [41.0](/filings/0001587523-26-000018.md) |
| Current assets | $m | [376](/filings/0001587523-23-000071.md) | [388](/filings/0001587523-23-000081.md) | [429](/filings/0001587523-25-000010.md) | [468](/filings/0001587523-24-000040.md) | [423](/filings/0001587523-24-000071.md) | [436](/filings/0001587523-24-000083.md) | [361](/filings/0001587523-26-000005.md) | [338](/filings/0001587523-25-000037.md) | [335](/filings/0001587523-25-000066.md) | [334](/filings/0001587523-25-000079.md) | [291](/filings/0001587523-26-000018.md) | [297](/filings/0001587523-26-000018.md) |
| Total assets | $m | [1,176](/filings/0001587523-23-000071.md) | [1,182](/filings/0001587523-23-000081.md) | [1,463](/filings/0001587523-26-000005.md) | [1,483](/filings/0001587523-24-000040.md) | [1,178](/filings/0001587523-24-000071.md) | [1,171](/filings/0001587523-24-000083.md) | [1,118](/filings/0001587523-26-000005.md) | [1,097](/filings/0001587523-25-000037.md) | [1,088](/filings/0001587523-25-000066.md) | [1,088](/filings/0001587523-25-000079.md) | [1,051](/filings/0001587523-26-000018.md) | [1,054](/filings/0001587523-26-000018.md) |
| Current liabilities | $m | [108](/filings/0001587523-23-000071.md) | [107](/filings/0001587523-23-000081.md) | [165](/filings/0001587523-25-000010.md) | [170](/filings/0001587523-24-000040.md) | [179](/filings/0001587523-24-000071.md) | [186](/filings/0001587523-24-000083.md) | [198](/filings/0001587523-26-000005.md) | [168](/filings/0001587523-25-000037.md) | [167](/filings/0001587523-25-000066.md) | [176](/filings/0001587523-25-000079.md) | [106](/filings/0001587523-26-000018.md) | [90.9](/filings/0001587523-26-000018.md) |
| Long-term debt | $m | [45.0](/filings/0001587523-23-000071.md) | [45.0](/filings/0001587523-23-000081.md) | [224](/filings/0001587523-25-000010.md) | [245](/filings/0001587523-24-000040.md) | [212](/filings/0001587523-24-000071.md) | [176](/filings/0001587523-24-000083.md) | [134](/filings/0001587523-26-000005.md) | [119](/filings/0001587523-25-000037.md) | [119](/filings/0001587523-25-000066.md) | [104](/filings/0001587523-25-000079.md) | [114](/filings/0001587523-26-000018.md) | [131](/filings/0001587523-26-000018.md) |
| Current portion of debt | $m | [45.0](/filings/0001587523-23-000071.md) | [45.0](/filings/0001587523-23-000081.md) | [47.1](/filings/0001587523-25-000010.md) | [48.0](/filings/0001587523-24-000040.md) | [48.8](/filings/0001587523-24-000071.md) | [49.5](/filings/0001587523-24-000083.md) | [68.5](/filings/0001587523-26-000005.md) | [69.8](/filings/0001587523-25-000037.md) | [71.0](/filings/0001587523-25-000066.md) | [72.3](/filings/0001587523-25-000079.md) | [0.0](/filings/0001587523-26-000005.md) | not reported |
| Short-term borrowings | $m | not reported | not reported | [50.0](/filings/0001587523-24-000017.md) | not reported | not reported | not reported | [72.7](/filings/0001587523-26-000005.md) | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,034](/filings/0001587523-25-000079.md) | [993](/filings/0001587523-24-000083.md) | [1,034](/filings/0001587523-26-000005.md) | [1,034](/filings/0001587523-25-000066.md) | [753](/filings/0001587523-25-000079.md) | [777](/filings/0001587523-25-000079.md) | [756](/filings/0001587523-26-000018.md) | [756](/filings/0001587523-26-000018.md) | [746](/filings/0001587523-25-000079.md) | [752](/filings/0001587523-25-000079.md) | [776](/filings/0001587523-26-000018.md) | [780](/filings/0001587523-26-000018.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [0.5 d](/filings/0001587523-24-000071.md) | [39.9 d](/filings/0001587523-24-000083.md) | not reported | [17.3](/filings/0001587523-25-000037.md) | [24.9 d](/filings/0001587523-25-000066.md) | [52.8 d](/filings/0001587523-25-000079.md) | not reported | [1.3](/filings/0001587523-26-000018.md) | [36.4 d](/filings/0001587523-25-000066.md) | [29.1 d](/filings/0001587523-25-000079.md) | not reported | [(0.7)](/filings/0001587523-26-000018.md) |
| Capital expenditure | $m | [4.0 d](/filings/0001587523-24-000071.md) | [3.9 d](/filings/0001587523-24-000083.md) | [5.1 d](/filings/0001587523-26-000005.md) | [3.4](/filings/0001587523-25-000037.md) | [3.2 d](/filings/0001587523-25-000066.md) | [3.7 d](/filings/0001587523-25-000079.md) | [3.3 d](/filings/0001587523-26-000005.md) | [4.0](/filings/0001587523-26-000018.md) | [5.1 d](/filings/0001587523-25-000066.md) | [7.7 d](/filings/0001587523-25-000079.md) | [15.3 d](/filings/0001587523-26-000005.md) | [10.8](/filings/0001587523-26-000018.md) |
| Share repurchases | $m | [5.0 d](/filings/0001587523-24-000071.md) | [15.0 d](/filings/0001587523-24-000083.md) | [20.0 d](/filings/0001587523-26-000005.md) | [0.0](/filings/0001587523-25-000037.md) | [25.0 d](/filings/0001587523-25-000066.md) | [4.5 d](/filings/0001587523-25-000079.md) | [24.2 d](/filings/0001587523-26-000005.md) | [5.0](/filings/0001587523-26-000018.md) | [30.0 d](/filings/0001587523-25-000066.md) | [20.0 d](/filings/0001587523-25-000079.md) | [10.0 d](/filings/0001587523-26-000005.md) | [7.5](/filings/0001587523-26-000018.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [92.0](/filings/0001587523-23-000071.md) | [92.0](/filings/0001587523-23-000081.md) | [91.4](/filings/0001587523-24-000040.md) | [91.8](/filings/0001587523-24-000071.md) | [91.4](/filings/0001587523-24-000083.md) | [89.6](/filings/0001587523-25-000037.md) | [89.9](/filings/0001587523-25-000066.md) | [89.7](/filings/0001587523-25-000079.md) | [87.8](/filings/0001587523-26-000018.md) | [87.6](/filings/0001587523-25-000066.md) | [87.3](/filings/0001587523-25-000079.md) | [87.7](/filings/0001587523-26-000018.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 85,560,660 at 2026-04-24, from the cover of the [10-Q filed 2026-04-28](/filings/0001587523-26-000018.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.